Nomizo, Takashi, Haruka Yamamoto, Tsunetaka Murayama, Hiroko Fukata, Yasukiyo Nakamura, Mami Sonomura, Aika Okuno, Naoki Kanda, Chihiro Watanabe, and Hideo Kita. “Immune-Related Adverse Events Caused by Combined Immune Checkpoint Inhibitor Therapy With Nivolumab and Ipilimumab for Lung Cancer”. Trends in Immunotherapy 6, no. 1 (January 14, 2022). Accessed April 3, 2025. https://ojs.ukscip.com/index.php/ti/article/view/425.